Live Yum Brands Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow NanoVibronix, Inc.

Get SEC filing alerts via email and in your feed for NanoVibronix, Inc.

NAOV

NanoVibronix, Inc.

About NanoVibronix, Inc.

NanoVibronix develops ultrasound and micro-vibration medical devices for pain management, wound healing, and infection prevention. Its core products include portable ultrasound patches and biofilm-reducing devices for urinary catheters, targeting healthcare facilities and home use. The company's value lies in non-invasive, cost-effective therapies that promote tissue regeneration, reduce infections, and enable patient independence, primarily serving global markets through direct sales and distribution partnerships.
This description was generated via AI from an annual report. Updated 10 months ago.

Latest SEC Filings from NanoVibronix, Inc.

1
1
NanoVibronix, Inc. ENvue Medical Reports 36% Revenue Decline and Increased Net Loss in Q1 2026

Via official filing (AI summary) | 2 months ago | 0 comments

2
1
NanoVibronix, Inc. ENvue Medical Reports $18.2 Million Net Loss for Fiscal Year 2025

Via official filing (AI summary) | 3 months ago | 0 comments

3
1
NanoVibronix, Inc. NanoVibronix Reports 92% Revenue Growth and Net Income Turnaround in Q3 2025

Via official filing (AI summary) | 8 months ago | 0 comments

4
1
NanoVibronix, Inc. NanoVibronix Reports Significant Revenue Decline and Increased Net Losses in Q2 2025

Via official filing (AI summary) | 11 months ago | 0 comments

5
1
NanoVibronix, Inc. NanoVibronix Reports 11% Revenue Growth but Significant Net Loss in Q1 2025

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
NanoVibronix, Inc. NanoVibronix Reports $3.7 Million Net Loss and 12% Revenue Growth for Fiscal Year 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

7
1
NanoVibronix, Inc. NanoVibronix Reports Mixed Q3 Results, Net Loss Increases, Raises Concerns Over Going Concern

Via official filing (AI summary) | over 1 year ago | 0 comments